Valuation: UCB

Market Cap 42.29B 48.79B 39.64B 36.15B 68.01B 4,656B 69.1B 467B 182B 2,331B 183B 179B 7,775B P/E 2026 *
22.2x
P/E 2027 * 18.3x
Enterprise Value 42.77B 49.34B 40.09B 36.56B 68.79B 4,709B 69.89B 472B 184B 2,357B 185B 181B 7,864B EV / Sales 2026 *
4.92x
EV / Sales 2027 * 4.18x
Free-Float
61.59%
Yield 2026 *
0.66%
Yield 2027 * 0.68%
1 day-1.22%
1 week-2.62%
Current month-1.70%
1 month-7.00%
3 months-8.36%
6 months-21.61%
Current year-8.17%
1 week 217.1
Extreme 217.1
228.8
1 month 214
Extreme 214
251.5
Current year 214
Extreme 214
289.5
1 year 189.5
Extreme 189.5
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 60 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%-2.62%+15.13%+166.74% 48.81B
+1.97%+5.39%+44.91%+0.66% 79.68B
+0.97%+4.90%-0.37%+26.99% 50.61B
-0.66%+5.25%-47.97%-48.32% 46.91B
+0.70%+2.14%+55.85%-22.75% 30.86B
+0.39%+18.44%+137.23%-36.21% 25.42B
-0.36%+1.55%+40.03%+84.27% 24.48B
-0.42%+5.37%+8.99%+187.03% 21.2B
-2.14%-1.23%+62.33%+159.21% 16.39B
+0.85%+0.63%+62.89%+109.43% 16.18B
Average +0.01%+3.11%+37.90%+62.71% 36.05B
Weighted average by Cap. +0.29%+2.82%+29.04%+44.59%

Financials

2026 *2027 *
Net sales 8.69B 10.02B 8.14B 7.43B 13.97B 957B 14.2B 95.9B 37.44B 479B 37.63B 36.81B 1,597B 9.69B 11.18B 9.08B 8.28B 15.58B 1,067B 15.83B 107B 41.76B 534B 41.97B 41.06B 1,782B
Net income 1.93B 2.22B 1.8B 1.65B 3.1B 212B 3.15B 21.25B 8.3B 106B 8.34B 8.16B 354B 2.33B 2.69B 2.18B 1.99B 3.74B 256B 3.8B 25.69B 10.03B 128B 10.08B 9.86B 428B
Net Debt 482M 557M 452M 412M 776M 53.12B 788M 5.33B 2.08B 26.59B 2.09B 2.04B 88.7B -1.8B -2.08B -1.69B -1.54B -2.89B -198B -2.94B -19.85B -7.75B -99.13B -7.79B -7.62B -331B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
26-08-13 219.10 -1.22% 216,220
26-08-12 €221.80 -1.95% 178,654
26-08-11 €226.20 +0.49% 170,849
26-08-10 €225.10 +0.90% 195,294
26-08-07 €223.10 -0.84% 194,018
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
221.80EUR
Average target price
285.26EUR
Spread / Average Target
+28.61%

Quarterly revenue - Rate of surprise